Subscribe
Subscribe to IHE
Institute of Health Economics logo
My IHE Login
  • About IHE
    • About
    • History
    • Board of Directors
    • Corporate Reports
    • Partnerships & Affiliations
    • Staff Directory
    • Careers and Awards
    • Privacy Policy
  • Research & Programs
    • Health Technology Assessment
    • Guideline Adaptation and Development
    • Health Economics
    • Industry Partnerships
    • Knowledge Transfer
    • Research Methodology Development
  • Publications
  • Events
    • Upcoming Events
    • Past Events
  • News
    • News
  • Contract Our Services
Home / Advanced Search

Advanced Search

Result Type

  • Publications
    • All Publications
    • Books
    • Consensus Statements
    • Economic Reports
    • Environmental Scan
    • Evidence Review
    • Health Technology Assessments /
      Systematic Reviews
    • Health Topic Overviews / Scoping Reviews
    • HTA Policy
    • IHE Discussion Paper
    • IHE Roundtable Report
    • Journal Articles
    • Methodology Papers
    • Overview of Systematic Reviews
    • Rapid Reviews
    • Statistics Handbooks
    • Summary Reports
  • Other Resources
    • All Resources
    • Backgrounders
    • Clinical Practice Guidelines
    • Clinical Tools
    • Event Proceedings
    • Patient Resources
    • Presentations
    • Programs
  • News/Events
  • General Content

Years

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 1996-2014
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
    • 2001
    • 2000
    • 1999
    • 1998
    • 1997
    • 1996

Topics

  • Cancer
  • Chronic Diseases / Disorders
  • Community Health Centres
  • Constraints
  • Core Data Set
  • Cost-effectiveness analysis
  • COVID-19
  • Diabetes
  • Diagnosis
  • Diagonal approach
  • Economic Evaluation
  • Fetal Alcohol Spectrum Disorder (FASD)
  • Health Economics / Healthcare Costs
  • Health Measurement Tools
  • Health Policy
  • Health Technology Assessment
  • Health Topic Overviews
  • Healthcare Services
  • Heart Disease
  • Infectious Diseases
  • Innovation
  • Life-Cycle
  • Maternal and Child Health
  • Mental Health
  • Nurse Practitioners
  • Opioid substance use disorder
  • Other
  • Pharmaceuticals
  • Precision Medicine
  • Precision Oncology
  • Prevention
  • Primary Care
  • Priority-Setting
  • Quality of Life
  • Regulatory Approval
  • Reimbursement
  • Scoping Reviews
  • Screening
  • Spillover effects
  • Surveillance
  • Telehealth
  • Therapy
  • Uncertainty
  • Vaccines

Authors

  • Akpinar, Ilke
  • Bond, Ken
  • Brown, Jasmine
  • Chojecki, Dagmara
  • Corabian, Paula
  • Guo, Bing
  • Harback, Kate
  • Institute of Health Economics, IHE
  • Kirwin, Erin
  • McCabe, Christopher
  • Moga, Carmen
  • Palfrey, Dan
  • Pollock, Michelle
  • Rafferty, Ellen
  • Razavilar, Negar
  • Round, Jeff
  • Seida, Jennifer
  • Sproule, John
  • Sutton, Andrew J.
  • Tjosvold, Lisa
  • Tran, Dat
  • Warkentin, Lindsey
  • Wright, Erica
  • Yan, Charles

The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.

If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!

Refine your search by clicking filters to the left.

Results for: Infectious Diseases

Early Economic Evaluation to Identify the Necessary Test Characteristics of a New Typhoid Test to be Cost Effective in Ghana

August 03, 2019

| Samuel N. Frempong, Andrew J. Sutton, Clare Davenport, Pelham Barton

The aim of this study, published in PharmacoEconomics – Open, was to conduct an early economic analysis of a hypothetical rapid test for typhoid fever diagnosis in Ghana and identify the necessary characteristics of the test for it to be cost effective in Ghana.

Benefit of adjunct universal rectal screening for Chlamydia genital infections in women attending Canadian sexually transmitted infection clinics

May 23, 2017

| Thanh Nguyen, Ilke Akpinar, Jennifer Gratrix, Sabrina Plitt, Petra Smyczek, Ron Read, Philip Jacobs, Tom Wong, Ameeta E Singh

Adding universal rectal screening to urogenital screening should positively impact rectal Chlamydia trachomatis (CT) incidence in affected populations. A dynamic Markov model was used to evaluate costs and outcomes of three rectal CT screening strategies among women attending sexually transmitted infection clinics in Alberta, Canada: universal urogenital-only screening (UG-only),…

Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010–2015)

September 30, 2015

| Arianna Waye, Anderson Chuck

Objective: In this study, we estimate the impact of the new PCV13 immunization program on the burden of disease and related healthcare costs in Alberta.

Effectiveness of Screening for Endemic Antibiotic Resistant Organisms (AROs) in Hospital Settings

July 18, 2014

| Ken Bond, Lisa Tjosvold, Christa Harstall

Summary of Systematic Reviews, Primary Studies, and Evidence-based Guidelines. The following research questions were addressed in this review: What are the clinical effects of a universal screening strategy for ARO carriage when compared with no screening? What are the clinical effects of a universal screening strategy for ARO carriage when compared with targeted screening (screening…

Consensus Statement on Surveillance & Screening for AROs (Antimicrobial-Resistant Organisms)

June 20, 2014

Antibiotic-Resistant Organisms (AROs) are a serious health problem, though they are more prevalent in some settings than others. We were asked to make findings and develop recommendations on how to address surveillance of and screening for AROs in acute care hospitals. This consensus statement addresses these requests. However, confining the discussion and recommendations to hospitals…

The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates

October 01, 2013

| Arianna Waye, Philip Jacobs, Ben Tan

  INTRODUCTION: Varicella vaccine was introduced to the infant immunization schedule in each province or territory between 2000 and 2007 as a result of the Canadian ImmunizationStrategy. The impact of vaccinating children against this disease is potentially far reaching, asimmunization may also benefit those segments of the population not immunized. The objective of this paper…

Aboriginal Peoples’ Wellness in Canada: Scaling Up the Knowledge; Cultural Context and Community Aspirations – Friday agenda

March 04, 2011

This one-day, invitational event engaged community experts and senior decision-makers involved in First Nations, Inuit, and Métis health policy in Canada in round-table discussions. Integrated Knowledge Exchange in health requires communities, researchers, and policy-makers utilize evidence from all sources in a culturally relevant way.

Fecal transplantation for the treatment of Clostridium difficile-associated disease or ulcerative colitis

March 01, 2011

| Bing Guo, Christa Harstall, Thanh Nguyen, Arto Ohinmaa

  Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). Fecal transplantation for the treatment of Clostridium difficile-associated disease or ulcerative colitis examines the clinical research evidence on the safety and effects of fecal transplantation in the treatment of patients with Clostridium difficile-associated disease…

Economics of Childhood Immunizations in Canada: Data Book

May 13, 2007

| Philip Jacobs, Rita Yim, Arto Ohinmaa, Janice Varney, Anita Hanrahan, Joy Loewen, Laura Mashinter, Bev Baptiste, Margaret Russell

This booklet is a compendium of existing statistics related to the economic aspect of childhood immunizations in Canada. It brings together, in one document, data obtained from a wide range of sources. It covers topics related to the economic and epidemiological burden of childhood diseases, resources used, and system performance from provincial, national, and international viewpoints.

Cost-effectiveness in the Detection of Syphilis

February 13, 2007

| Anderson Chuck, Philip Jacobs, Thanh Nguyen, Arto Ohinmaa, Janice Varney

Evaluation of enzyme immunoassay and immunoblot testing for the diagnosis of syphilis in Alberta. A new protocol for testing and diagnosing syphilis has been proposed in Alberta. The protocol proposes replacing rapid plasma reagin (RPR) with enzyme immunoassay (EIA) as the standard initial test and replacing Treponema pallidum (T. pallidum) particle agglutination assay (TPPA) and…

  • Site Map
  • Privacy Policy
  • Contact Us & Subscribe
  • Home

Copyright © 2022 Institute of Health Economics

Institute of Health Economics 1200 10405 Jasper Avenue Edmonton, AB, Canada T5J 3N4

P: (1) 780.448.4881 F: (1) 780.448.0018
Email: [email protected]

Links

Canada

United States

United Kingdom

Other International

Journals

Health Economics Resources

Free Database Access

Never miss an update!

Subscribe to IHE